HLA-B61 antigen

Also Known As:

HLA Bw61; HLA-B61; HLA-Bw61; HLA-Bw61 antigen

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Glycoconjugates: 1353
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4
Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Glycoproteins: 24834
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4
  - Membrane Proteins: 10078
    - Membrane Glycoproteins: 2252
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4
Biological Factors: 2472
- Antigens: 143924
  - Surface Antigens: 5813
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4
  - Isoantigens: 1221
    - Histocompatibility Antigens: 1132
      - HLA Antigens: 8934
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4
      - Histocompatibility Antigens Class I: 1944
        HLA-B Antigens: 1869
        HLA-B61 antigen: 4

Experts

1.	Bres-Vloemans, S A: 1 article (10/2006)
2.	Camps, M: 1 article (10/2006)
3.	Drijfhout, J W: 1 article (10/2006)
4.	Huijbers, I J G: 1 article (10/2006)
5.	Kessler, J H: 1 article (10/2006)
6.	Leeksma, O C: 1 article (10/2006)
7.	Melief, C J M: 1 article (10/2006)
8.	Mulder, A: 1 article (10/2006)
9.	Offringa, R: 1 article (10/2006)
10.	Ossendorp, F: 1 article (10/2006)

Related Diseases

1.	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/01/2006 - "CTL raised against the properly processed HLA-B61 epitope AEALQRPVA from the BCR-ABL e1a2 fusion region, expressed in acute lymphoblastic leukemia (ALL), specifically recognized ALL tumor cells, proving cell surface presentation of this epitope, its applicability for immunotherapy and underlining the accuracy of our epitope identification strategy. "
2.	Neoplasms (Cancer) 10/01/2006 - "CTL raised against the properly processed HLA-B61 epitope AEALQRPVA from the BCR-ABL e1a2 fusion region, expressed in acute lymphoblastic leukemia (ALL), specifically recognized ALL tumor cells, proving cell surface presentation of this epitope, its applicability for immunotherapy and underlining the accuracy of our epitope identification strategy. "
3.	Melanoma (Melanoma, Malignant) 05/01/1996 - "The frequency of HLA-B13 was increased in melanoma patients compared to controls and was particularly common in nodular melanoma HLA-B61 was decreased in melanoma patients. "
4.	Autoimmune Diseases (Autoimmune Disease) 03/01/1990 - "The HLA-DRw9 phenotype and HLA-Bw61/DRw9 haplotype were significantly increased among the patients with autoantibodies other than ICA but with no autoimmune diseases (RR = 5.84, cP less than 0.001; and RR = 7.45, P less than 0.001), whereas the HLA-DR4 phenotype and HLA-Bw54/DR4 haplotype were significantly increased in those without either the autoantibodies or autoimmune diseases (RR = 2.64, cP less than 0.001; and RR = 4.55, P less than 0.001). "
5.	Asthma (Bronchial Asthma) 10/01/1988 - "Association of HLA-Bw61 with asthma in the Chinese."

Related Drugs and Biologics

1.	HLA-B13 Antigen
2.	HLA-DR4 Antigen (HLA DR4 Antigen)
3.	Autoantibodies
4.	Epitopes
5.	HLA-B54 antigen
6.	HLA-DR9 antigen

Related Therapies and Procedures

1.	Immunotherapy